Desvenlafaxine Succinate (CAS 386750-22-7) is a complex organic compound that plays a critical role as a pharmaceutical intermediate. Understanding its chemical and physical 'desvenlafaxine succinate properties' is essential for anyone involved in its synthesis, procurement, or utilization in drug manufacturing. Typically presented as a white crystalline powder, its high purity, often exceeding 99%, is a testament to sophisticated synthesis and purification processes employed by specialized 'desvenlafaxine succinate manufacturers'.

The chemical structure of Desvenlafaxine Succinate makes it an ideal precursor for the synthesis of desvenlafaxine, an active pharmaceutical ingredient (API) widely used in the treatment of depression. The specific 'desvenlafaxine succinate uses' are therefore concentrated within the pharmaceutical industry, where precision and reliability are paramount. The production of such intermediates requires meticulous attention to detail, from raw material selection to the final packaging, ensuring that the product meets all required specifications. For instance, knowing the solubility and stability characteristics is vital for process chemists when planning the next steps in the synthesis.

When considering where to 'buy Desvenlafaxine Succinate', it is important to partner with suppliers who not only offer competitive 'desvenlafaxine succinate price' points but also demonstrate a strong commitment to quality assurance and regulatory compliance. Companies like Ningbo Inno Pharmchem Co., Ltd. are recognized for their expertise in producing high-grade 'pharmaceutical intermediate desvenlafaxine succinate'. They invest in advanced manufacturing technologies and robust quality control systems to guarantee the consistency and purity of their products. The 'desvenlafaxine succinate CAS number' serves as a critical identifier, ensuring that the correct compound is being handled throughout the supply chain.

The production of Desvenlafaxine Succinate is a sophisticated chemical endeavor. Manufacturers must navigate complex synthesis routes, manage potential impurities, and ensure that their operations meet global pharmaceutical standards. The continued demand for effective antidepressants means that the role of reliable 'desvenlafaxine succinate manufacturers' will remain indispensable in bringing these vital medications to market.